ID PTC1_HUMAN Reviewed; 1447 AA. AC Q13635; A3KBI9; E9PEJ8; Q13463; Q5R1U7; Q5R1U9; Q5R1V0; Q5VZC0; AC Q5VZC2; Q86XG7; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 23-OCT-2007, sequence version 2. DT 16-OCT-2013, entry version 139. DE RecName: Full=Protein patched homolog 1; DE Short=PTC; DE Short=PTC1; GN Name=PTCH1; Synonyms=PTCH; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM L), AND VARIANTS BCC PRO-175; RP PRO-ASN-ILE-815 INS AND LEU-1315. RC TISSUE=Lung; RX PubMed=8658145; DOI=10.1126/science.272.5268.1668; RA Johnson R.L., Rothman A.L., Xie J., Goodrich L.V., Bare J.W., RA Bonifas J.M., Quinn A.G., Myers R.M., Cox D.R., Epstein E.H. Jr., RA Scott M.P.; RT "Human homolog of patched, a candidate gene for the basal cell nevus RT syndrome."; RL Science 272:1668-1671(1996). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM S), AND VARIANT LEU-1315. RC TISSUE=Fetal brain; RX PubMed=8647801; DOI=10.1074/jbc.271.21.12125; RA Hahn H., Christiansen J., Wicking C., Zaphiropolous P.G., RA Chidambaram A., Gerrard B., Vorechovsky I., Bale A.E., Toftgard R., RA Dean M., Wainwright B.J.; RT "A mammalian patched homolog is expressed in target tissues of sonic RT hedgehog and maps to a region associated with developmental RT abnormalities."; RL J. Biol. Chem. 271:12125-12128(1996). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164053; DOI=10.1038/nature02465; RA Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., RA Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., RA Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., RA Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R., RA Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P., RA Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W., RA Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G., RA Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M., RA Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W., RA Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A., RA Frankland J.A., French L., Fricker D.G., Garner P., Garnett J., RA Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., RA Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., RA Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., RA Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., RA Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., RA Kimberley A.M., King A., Knights A., Laird G.K., Langford C., RA Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., RA Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., RA McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J., RA Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R., RA Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M., RA Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M., RA Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A., RA Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P., RA Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W., RA Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., RA Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., RA Rogers J., Dunham I.; RT "DNA sequence and analysis of human chromosome 9."; RL Nature 429:369-374(2004). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-324 (ISOFORM L'), NUCLEOTIDE SEQUENCE RP [MRNA] OF 1-259 (ISOFORM M), NUCLEOTIDE SEQUENCE [MRNA] OF 1-174 RP (ISOFORM S), AND ALTERNATIVE SPLICING. RX PubMed=15780749; DOI=10.1016/j.ygeno.2004.11.014; RA Nagao K., Toyoda M., Takeuchi-Inoue K., Fujii K., Yamada M., RA Miyashita T.; RT "Identification and characterization of multiple isoforms of a murine RT and human tumor suppressor, patched, having distinct first exons."; RL Genomics 85:462-471(2005). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-183 (ISOFORM M). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-90 (ISOFORM S), AND ALTERNATIVE RP SPLICING. RX PubMed=17310997; DOI=10.1038/sj.onc.1210301; RA Shimokawa T., Svard J., Heby-Henricson K., Teglund S., Toftgard R., RA Zaphiropoulos P.G.; RT "Distinct roles of first exon variants of the tumor-suppressor RT Patched1 in Hedgehog signaling."; RL Oncogene 26:4889-4896(2007). RN [7] RP INTERACTION WITH SNX17. RX PubMed=15769472; DOI=10.1016/j.jmb.2005.02.004; RA Knauth P., Schlueter T., Czubayko M., Kirsch C., Florian V., RA Schreckenberger S., Hahn H., Bohnensack R.; RT "Functions of sorting nexin 17 domains and recognition motif for P- RT selectin trafficking."; RL J. Mol. Biol. 347:813-825(2005). RN [8] RP FUNCTION, AND INTERACTION WITH IHH. RX PubMed=21537345; DOI=10.1038/cr.2011.76; RA Ma G., Yu J., Xiao Y., Chan D., Gao B., Hu J., He Y., Guo S., Zhou J., RA Zhang L., Gao L., Zhang W., Kang Y., Cheah K.S., Feng G., Guo X., RA Wang Y., Zhou C.Z., He L.; RT "Indian hedgehog mutations causing brachydactyly type A1 impair RT Hedgehog signal transduction at multiple levels."; RL Cell Res. 21:1343-1357(2011). RN [9] RP VARIANTS BCNS ARG-509; VAL-509; GLN-816 DEL AND TYR-1132. RX PubMed=8840969; RA Chidambaram A., Goldstein A.M., Gailani M.R., Gerrard B., Bale S.J., RA DiGiovanna J.J., Bale A.E., Dean M.; RT "Mutations in the human homologue of the Drosophila patched gene in RT Caucasian and African-American nevoid basal cell carcinoma syndrome RT patients."; RL Cancer Res. 56:4599-4601(1996). RN [10] RP VARIANTS BCNS TYR-513 AND ARG-1069. RX PubMed=8981943; RA Wicking C., Shanley S., Smyth I., Gillies S., Negus K., Graham S., RA Suthers G., Haites N., Edwards M., Wainwright B.J., RA Chenevix-Trench G.; RT "Most germ-line mutations in the nevoid basal cell carcinoma syndrome RT lead to a premature termination of the PATCHED protein, and no RT genotype-phenotype correlations are evident."; RL Am. J. Hum. Genet. 60:21-26(1997). RN [11] RP VARIANT NBCCS ASP-1438. RX PubMed=9341860; DOI=10.1007/s004390050541; RA Lench N.J., Telford E.A.R., High A.S., Markham A.F., Wicking C., RA Wainwright B.J.; RT "Characterisation of human patched germ line mutations in naevoid RT basal cell carcinoma syndrome."; RL Hum. Genet. 100:497-502(1997). RN [12] RP VARIANT LEU-1315. RX PubMed=10200051; RX DOI=10.1002/(SICI)1098-1004(1998)11:6<480::AID-HUMU9>3.3.CO;2-W; RA Hasenpusch-Theil K., Bataille V., Laehdetie J., Obermayr F., RA Sampson J.R., Frischauf A.-M.; RT "Gorlin syndrome: identification of 4 novel germ-line mutations of the RT human patched (PTCH) gene."; RL Hum. Mutat. 11:480-480(1998). RN [13] RP VARIANTS BCNS SER-376 AND VAL-1083 INS, AND VARIANT BCC TRP-1114. RX PubMed=9620294; DOI=10.1046/j.1523-1747.1998.00222.x; RA Aszterbaum M., Rothman A.L., Johnson R.L., Fisher M., Xie J., RA Bonifas J.M., Zhang X., Scott M.P., Epstein E.H. Jr.; RT "Identification of mutations in the human PATCHED gene in sporadic RT basal cell carcinomas and in patients with the basal cell nevus RT syndrome."; RL J. Invest. Dermatol. 110:885-888(1998). RN [14] RP VARIANT LEU-1315. RX PubMed=10874314; RX DOI=10.1002/1098-1004(200007)16:1<89::AID-HUMU18>3.3.CO;2-Z; RA Dong J., Gailani M.R., Pomeroy S.L., Reardon D., Bale A.E.; RT "Identification of PATCHED mutations in medulloblastomas by direct RT sequencing."; RL Hum. Mutat. 16:89-90(2000). RN [15] RP VARIANT BCNS PRO-1132. RX PubMed=11231326; DOI=10.1046/j.1523-1747.2001.01279-2.x; RA Reifenberger J., Arnold N., Kiechle M., Reifenberger G., Hauschild A.; RT "Coincident PTCH and BRCA1 germline mutations in a patient with nevoid RT basal cell carcinoma syndrome and familial breast cancer."; RL J. Invest. Dermatol. 116:472-474(2001). RN [16] RP VARIANTS SQUAMOUS CELL CARCINOMA MET-829 AND LYS-1242. RX PubMed=11286632; DOI=10.1046/j.1523-1747.2001.01301.x; RA Ping X.L., Ratner D., Zhang H., Wu X.L., Zhang M.J., Chen F.F., RA Silvers D.N., Peacocke M., Tsou H.C.; RT "PTCH mutations in squamous cell carcinoma of the skin."; RL J. Invest. Dermatol. 116:614-616(2001). RN [17] RP VARIANTS HPE7 THR-393; MET-728; GLY-827 AND MET-1052. RX PubMed=11941477; DOI=10.1007/s00439-002-0695-5; RA Ming J.E., Kaupas M.E., Roessler E., Brunner H.G., Golabi M., RA Tekin M., Stratton R.F., Sujansky E., Bale S.J., Muenke M.; RT "Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are RT associated with holoprosencephaly."; RL Hum. Genet. 110:297-301(2002). RN [18] RP ERRATUM. RA Ming J.E., Kaupas M.E., Roessler E., Brunner H.G., Golabi M., RA Tekin M., Stratton R.F., Sujansky E., Bale S.J., Muenke M.; RL Hum. Genet. 111:464-464(2002). RN [19] RP VARIANTS BCNS PRO-230 AND 505-LEU-ARG-506. RX PubMed=15459969; DOI=10.1002/humu.9289; RA Savino M., d'Apolito M., Formica V., Baorda F., Mari F., Renieri A., RA Carabba E., Tarantino E., Andreucci E., Belli S., Lo Muzio L., RA Dallapiccola B., Zelante L., Savoia A.; RT "Spectrum of PTCH mutations in Italian nevoid basal cell-carcinoma RT syndrome patients: identification of thirteen novel alleles."; RL Hum. Mutat. 24:441-441(2004). RN [20] RP VARIANT HPE7 MET-728. RX PubMed=17096318; DOI=10.1002/ajmg.a.31370; RA Rahimov F., Ribeiro L.A., de Miranda E., Richieri-Costa A., RA Murray J.C.; RT "GLI2 mutations in four Brazilian patients: how wide is the phenotypic RT spectrum?"; RL Am. J. Med. Genet. A 140:2571-2576(2006). RN [21] RP VARIANTS HPE7 GLY-443; GLY-751; GLY-908 AND MET-1052. RX PubMed=17001668; DOI=10.1002/ajmg.a.31369; RA Ribeiro L.A., Murray J.C., Richieri-Costa A.; RT "PTCH mutations in four Brazilian patients with holoprosencephaly and RT in one with holoprosencephaly-like features and normal MRI."; RL Am. J. Med. Genet. A 140:2584-2586(2006). CC -!- FUNCTION: Acts as a receptor for sonic hedgehog (SHH), indian CC hedgehog (IHH) and desert hedgehog (DHH). Associates with the CC smoothened protein (SMO) to transduce the hedgehog's proteins CC signal. Seems to have a tumor suppressor function, as inactivation CC of this protein is probably a necessary, if not sufficient step CC for tumorigenesis. CC -!- SUBUNIT: Interacts with SNX17. Interacts with IHH. CC -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Name=L; Synonyms=1B; CC IsoId=Q13635-1; Sequence=Displayed; CC Name=L'; Synonyms=1Ckid; CC IsoId=Q13635-2; Sequence=VSP_041369; CC Name=M; Synonyms=1C; CC IsoId=Q13635-3; Sequence=VSP_041371; CC Name=S; Synonyms=1A, 1CdeltaE2; CC IsoId=Q13635-4; Sequence=VSP_041370; CC -!- TISSUE SPECIFICITY: In the adult, expressed in brain, lung, liver, CC heart, placenta, skeletal muscle, pancreas and kidney. Expressed CC in tumor cells but not in normal skin. CC -!- DEVELOPMENTAL STAGE: In the embryo, found in all major target CC tissues of sonic hedgehog, such as the ventral neural tube, CC somites, and tissues surrounding the zone of polarizing activity CC of the limb bud. CC -!- PTM: Glycosylation is necessary for SHH binding (By similarity). CC -!- DISEASE: Basal cell nevus syndrome (BCNS) [MIM:109400]: An CC autosomal dominant disease characterized by nevoid basal cell CC carcinomas and developmental abnormalities such as rib and CC craniofacial alterations, polydactyly, syndactyly, and spina CC bifida. In addition, the patients suffer from a multitude of CC tumors like basal cell carcinomas, fibromas of the ovaries and CC heart, cysts of the skin, jaws and mesentery, as well as CC medulloblastomas and meningiomas. Note=The disease may be caused CC by mutations affecting the gene represented in this entry. CC -!- DISEASE: Basal cell carcinoma (BCC) [MIM:605462]: A common CC malignant skin neoplasm that typically appears on hair-bearing CC skin, most commonly on sun-exposed areas. BCC is slow growing and CC rarely metastasizes, but has potentialities for local invasion and CC destruction. It usually develops as a flat, firm, pale area that CC is small, raised, pink or red, translucent, shiny, and waxy, and CC the area may bleed following minor injury. Tumor size can vary CC from a few millimeters to several centimeters in diameter. CC Note=The disease is caused by mutations affecting the gene CC represented in this entry. CC -!- DISEASE: Holoprosencephaly 7 (HPE7) [MIM:610828]: A structural CC anomaly of the brain, in which the developing forebrain fails to CC correctly separate into right and left hemispheres. CC Holoprosencephaly is genetically heterogeneous and associated with CC several distinct facies and phenotypic variability. Note=The CC disease is caused by mutations affecting the gene represented in CC this entry. CC -!- SIMILARITY: Belongs to the patched family. CC -!- SIMILARITY: Contains 1 SSD (sterol-sensing) domain. CC -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology CC and Haematology; CC URL="http://atlasgeneticsoncology.org/Genes/PTCH100.html"; CC -!- WEB RESOURCE: Name=GeneReviews; CC URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/PTCH1"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U59464; AAC50550.1; -; mRNA. DR EMBL; U43148; AAC50496.1; -; mRNA. DR EMBL; AL161729; CAH73817.1; -; Genomic_DNA. DR EMBL; AL161729; CAH73818.1; -; Genomic_DNA. DR EMBL; AB189436; BAD74184.1; -; mRNA. DR EMBL; AB189437; BAD74185.1; -; mRNA. DR EMBL; AB189438; BAD74186.1; -; mRNA. DR EMBL; AB189439; BAD74187.1; -; mRNA. DR EMBL; AB189440; BAD74188.1; -; mRNA. DR EMBL; BC043542; AAH43542.1; -; mRNA. DR EMBL; AB239329; BAF47712.1; -; mRNA. DR IPI; IPI00014374; -. DR IPI; IPI00643862; -. DR IPI; IPI00654901; -. DR IPI; IPI00844057; -. DR RefSeq; NP_000255.2; NM_000264.3. DR RefSeq; NP_001077071.1; NM_001083602.1. DR RefSeq; NP_001077072.1; NM_001083603.1. DR RefSeq; NP_001077073.1; NM_001083604.1. DR RefSeq; NP_001077074.1; NM_001083605.1. DR RefSeq; NP_001077075.1; NM_001083606.1. DR RefSeq; NP_001077076.1; NM_001083607.1. DR UniGene; Hs.494538; -. DR ProteinModelPortal; Q13635; -. DR DIP; DIP-44940N; -. DR MINT; MINT-1543380; -. DR STRING; 9606.ENSP00000332353; -. DR PhosphoSite; Q13635; -. DR DMDM; 160415977; -. DR PaxDb; Q13635; -. DR PRIDE; Q13635; -. DR DNASU; 5727; -. DR Ensembl; ENST00000331920; ENSP00000332353; ENSG00000185920. DR Ensembl; ENST00000375274; ENSP00000364423; ENSG00000185920. DR Ensembl; ENST00000418258; ENSP00000396135; ENSG00000185920. DR Ensembl; ENST00000421141; ENSP00000399981; ENSG00000185920. DR Ensembl; ENST00000429896; ENSP00000414823; ENSG00000185920. DR Ensembl; ENST00000430669; ENSP00000410287; ENSG00000185920. DR Ensembl; ENST00000437951; ENSP00000389744; ENSG00000185920. DR Ensembl; ENST00000468211; ENSP00000449745; ENSG00000185920. DR Ensembl; ENST00000546820; ENSP00000448843; ENSG00000185920. DR Ensembl; ENST00000547672; ENSP00000447878; ENSG00000185920. DR Ensembl; ENST00000551845; ENSP00000447008; ENSG00000185920. DR Ensembl; ENST00000553011; ENSP00000447797; ENSG00000185920. DR GeneID; 5727; -. DR KEGG; hsa:5727; -. DR UCSC; uc004avk.4; human. DR CTD; 5727; -. DR GeneCards; GC09M098205; -. DR HGNC; HGNC:9585; PTCH1. DR HPA; CAB013717; -. DR MIM; 109400; phenotype. DR MIM; 601309; gene. DR MIM; 605462; phenotype. DR MIM; 610828; phenotype. DR neXtProt; NX_Q13635; -. DR Orphanet; 93925; Alobar holoprosencephaly. DR Orphanet; 377; Gorlin syndrome. DR Orphanet; 93924; Lobar holoprosencephaly. DR Orphanet; 280200; Microform holoprosencephaly. DR Orphanet; 93926; Midline interhemispheric variant of holoprosencephaly. DR Orphanet; 220386; Semilobar holoprosencephaly. DR Orphanet; 280195; Septopreoptic holoprosencephaly. DR PharmGKB; PA33937; -. DR eggNOG; NOG313603; -. DR HOVERGEN; HBG003801; -. DR InParanoid; Q13635; -. DR KO; K06225; -. DR OMA; PDRDYLH; -. DR OrthoDB; EOG40S0DT; -. DR PhylomeDB; Q13635; -. DR Reactome; REACT_111102; Signal Transduction. DR SignaLink; Q13635; -. DR ChiTaRS; PTCH1; human. DR GeneWiki; PTCH1; -. DR GenomeRNAi; 5727; -. DR NextBio; 22266; -. DR PRO; PR:Q13635; -. DR ArrayExpress; Q13635; -. DR Bgee; Q13635; -. DR CleanEx; HS_PTCH1; -. DR Genevestigator; Q13635; -. DR GO; GO:0005901; C:caveola; IDA:BHF-UCL. DR GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:BHF-UCL. DR GO; GO:0030496; C:midbody; IEA:Ensembl. DR GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL. DR GO; GO:0072372; C:primary cilium; IEA:Ensembl. DR GO; GO:0015485; F:cholesterol binding; IDA:BHF-UCL. DR GO; GO:0008158; F:hedgehog receptor activity; IEA:InterPro. DR GO; GO:0008201; F:heparin binding; IEA:Ensembl. DR GO; GO:0007420; P:brain development; ISS:BHF-UCL. DR GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl. DR GO; GO:0061005; P:cell differentiation involved in kidney development; IEA:Ensembl. DR GO; GO:0072203; P:cell proliferation involved in metanephros development; IEA:Ensembl. DR GO; GO:0071397; P:cellular response to cholesterol; IMP:BHF-UCL. DR GO; GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB. DR GO; GO:0030326; P:embryonic limb morphogenesis; ISS:UniProtKB. DR GO; GO:0008544; P:epidermis development; IEA:Ensembl. DR GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl. DR GO; GO:0003007; P:heart morphogenesis; IEA:Ensembl. DR GO; GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl. DR GO; GO:0043616; P:keratinocyte proliferation; IEA:Ensembl. DR GO; GO:0060603; P:mammary gland duct morphogenesis; IEA:Ensembl. DR GO; GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl. DR GO; GO:0051782; P:negative regulation of cell division; IEA:Ensembl. DR GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl. DR GO; GO:0040015; P:negative regulation of multicellular organism growth; ISS:UniProtKB. DR GO; GO:0045668; P:negative regulation of osteoblast differentiation; IMP:BHF-UCL. DR GO; GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL. DR GO; GO:0045879; P:negative regulation of smoothened signaling pathway; ISS:BHF-UCL. DR GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL. DR GO; GO:0021997; P:neural plate axis specification; ISS:BHF-UCL. DR GO; GO:0001843; P:neural tube closure; IEA:Ensembl. DR GO; GO:0021532; P:neural tube patterning; IMP:BHF-UCL. DR GO; GO:0009887; P:organ morphogenesis; ISS:UniProtKB. DR GO; GO:0060037; P:pharyngeal system development; IMP:BHF-UCL. DR GO; GO:0010875; P:positive regulation of cholesterol efflux; IDA:BHF-UCL. DR GO; GO:0016485; P:protein processing; ISS:UniProtKB. DR GO; GO:0072661; P:protein targeting to plasma membrane; IDA:BHF-UCL. DR GO; GO:0007346; P:regulation of mitotic cell cycle; IEA:Ensembl. DR GO; GO:0032880; P:regulation of protein localization; IEA:Ensembl. DR GO; GO:0072001; P:renal system development; IEP:UniProtKB. DR GO; GO:0010157; P:response to chlorate; IEA:Ensembl. DR GO; GO:0007224; P:smoothened signaling pathway; IEP:UniProtKB. DR GO; GO:0060831; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl. DR GO; GO:0061053; P:somite development; IMP:BHF-UCL. DR GO; GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl. DR InterPro; IPR003392; Patched. DR InterPro; IPR000731; SSD. DR InterPro; IPR004766; TM_rcpt_patched. DR Pfam; PF02460; Patched; 1. DR TIGRFAMs; TIGR00918; 2A060602; 1. DR PROSITE; PS50156; SSD; 1. PE 1: Evidence at protein level; KW Alternative splicing; Complete proteome; Disease mutation; KW Glycoprotein; Holoprosencephaly; Membrane; Polymorphism; Receptor; KW Reference proteome; Transmembrane; Transmembrane helix; KW Tumor suppressor. FT CHAIN 1 1447 Protein patched homolog 1. FT /FTId=PRO_0000205964. FT TOPO_DOM 1 100 Cytoplasmic (Potential). FT TRANSMEM 101 121 Helical; (Potential). FT TOPO_DOM 122 436 Extracellular (Potential). FT TRANSMEM 437 457 Helical; (Potential). FT TOPO_DOM 458 472 Cytoplasmic (Potential). FT TRANSMEM 473 493 Helical; (Potential). FT TOPO_DOM 494 501 Extracellular (Potential). FT TRANSMEM 502 522 Helical; (Potential). FT TOPO_DOM 523 547 Cytoplasmic (Potential). FT TRANSMEM 548 568 Helical; (Potential). FT TOPO_DOM 569 577 Extracellular (Potential). FT TRANSMEM 578 598 Helical; (Potential). FT TOPO_DOM 599 748 Cytoplasmic (Potential). FT TRANSMEM 749 769 Helical; (Potential). FT TOPO_DOM 770 1027 Extracellular (Potential). FT TRANSMEM 1028 1048 Helical; (Potential). FT TOPO_DOM 1049 1055 Cytoplasmic (Potential). FT TRANSMEM 1056 1076 Helical; (Potential). FT TOPO_DOM 1077 1083 Extracellular (Potential). FT TRANSMEM 1084 1104 Helical; (Potential). FT TOPO_DOM 1105 1121 Cytoplasmic (Potential). FT TRANSMEM 1122 1141 Helical; (Potential). FT TOPO_DOM 1142 1154 Extracellular (Potential). FT TRANSMEM 1155 1175 Helical; (Potential). FT TOPO_DOM 1176 1447 Cytoplasmic (Potential). FT DOMAIN 438 598 SSD. FT COMPBIAS 14 31 Gly-rich. FT CARBOHYD 141 141 N-linked (GlcNAc...) (Potential). FT CARBOHYD 312 312 N-linked (GlcNAc...) (Potential). FT CARBOHYD 349 349 N-linked (GlcNAc...) (Potential). FT CARBOHYD 414 414 N-linked (GlcNAc...) (Potential). FT CARBOHYD 875 875 N-linked (GlcNAc...) (Potential). FT CARBOHYD 1000 1000 N-linked (GlcNAc...) (Potential). FT VAR_SEQ 1 66 MASAGNAAEPQDRGGGGSGCIGAPGRPAGGGRRRRTGGLRR FT AAAPDRDYLHRPSYCDAAFALEQIS -> MELLNRNRLVIV FT SPRCTPPKASGGPARRGFYTFRSFCKDGGGGEEEEENGGEE FT KDDRGDKETRSD (in isoform L'). FT /FTId=VSP_041369. FT VAR_SEQ 2 152 Missing (in isoform S). FT /FTId=VSP_041370. FT VAR_SEQ 2 67 Missing (in isoform M). FT /FTId=VSP_041371. FT VARIANT 175 175 L -> P (in BCNS; sporadic BCC). FT /FTId=VAR_007843. FT VARIANT 230 230 T -> P (in BCNS). FT /FTId=VAR_020845. FT VARIANT 376 376 F -> S (in BCNS). FT /FTId=VAR_007844. FT VARIANT 393 393 A -> T (in HPE7). FT /FTId=VAR_032952. FT VARIANT 443 443 A -> G (in HPE7). FT /FTId=VAR_032953. FT VARIANT 505 506 FL -> LR (in BCNS). FT /FTId=VAR_020846. FT VARIANT 509 509 G -> R (in BCNS; could be a rare FT polymorphism). FT /FTId=VAR_010974. FT VARIANT 509 509 G -> V (in BCNS). FT /FTId=VAR_010975. FT VARIANT 513 513 D -> Y (in BCNS). FT /FTId=VAR_010976. FT VARIANT 728 728 T -> M (in HPE7; dbSNP:rs28936404). FT /FTId=VAR_032954. FT VARIANT 751 751 V -> G (in HPE7). FT /FTId=VAR_032955. FT VARIANT 815 815 I -> IPNI (in BCNS). FT /FTId=VAR_007845. FT VARIANT 816 816 Missing (in BCNS). FT /FTId=VAR_010977. FT VARIANT 827 827 S -> G (in HPE7; dbSNP:rs199476092). FT /FTId=VAR_032956. FT VARIANT 829 829 V -> M (in squamous cell carcinoma). FT /FTId=VAR_010978. FT VARIANT 908 908 V -> G (in HPE7). FT /FTId=VAR_032957. FT VARIANT 1052 1052 T -> M (in HPE7; dbSNP:rs28936405). FT /FTId=VAR_032958. FT VARIANT 1069 1069 G -> R (in BCNS). FT /FTId=VAR_010979. FT VARIANT 1083 1083 V -> VV (in BCNS). FT /FTId=VAR_007846. FT VARIANT 1114 1114 R -> W (in BCNS and BCC). FT /FTId=VAR_007847. FT VARIANT 1132 1132 S -> P (in BCNS). FT /FTId=VAR_010980. FT VARIANT 1132 1132 S -> Y (in BCNS). FT /FTId=VAR_010981. FT VARIANT 1195 1195 T -> S (in dbSNP:rs2236405). FT /FTId=VAR_020440. FT VARIANT 1242 1242 E -> K (in squamous cell carcinoma). FT /FTId=VAR_010982. FT VARIANT 1282 1282 P -> L (in dbSNP:rs2227968). FT /FTId=VAR_020847. FT VARIANT 1315 1315 P -> L (in dbSNP:rs357564). FT /FTId=VAR_010983. FT VARIANT 1438 1438 E -> D (in BCNS; sporadic NBCCS). FT /FTId=VAR_010984. FT CONFLICT 1109 1109 G -> S (in Ref. 2; AAC50496). FT CONFLICT 1144 1144 E -> D (in Ref. 2; AAC50496). FT CONFLICT 1175 1175 L -> W (in Ref. 2; AAC50496). FT CONFLICT 1283 1283 R -> K (in Ref. 2; AAC50496). FT CONFLICT 1309 1309 E -> K (in Ref. 2; AAC50496). FT CONFLICT 1353 1353 A -> T (in Ref. 2; AAC50496). SQ SEQUENCE 1447 AA; 160545 MW; F2937247BC812F85 CRC64; MASAGNAAEP QDRGGGGSGC IGAPGRPAGG GRRRRTGGLR RAAAPDRDYL HRPSYCDAAF ALEQISKGKA TGRKAPLWLR AKFQRLLFKL GCYIQKNCGK FLVVGLLIFG AFAVGLKAAN LETNVEELWV EVGGRVSREL NYTRQKIGEE AMFNPQLMIQ TPKEEGANVL TTEALLQHLD SALQASRVHV YMYNRQWKLE HLCYKSGELI TETGYMDQII EYLYPCLIIT PLDCFWEGAK LQSGTAYLLG KPPLRWTNFD PLEFLEELKK INYQVDSWEE MLNKAEVGHG YMDRPCLNPA DPDCPATAPN KNSTKPLDMA LVLNGGCHGL SRKYMHWQEE LIVGGTVKNS TGKLVSAHAL QTMFQLMTPK QMYEHFKGYE YVSHINWNED KAAAILEAWQ RTYVEVVHQS VAQNSTQKVL SFTTTTLDDI LKSFSDVSVI RVASGYLLML AYACLTMLRW DCSKSQGAVG LAGVLLVALS VAAGLGLCSL IGISFNAATT QVLPFLALGV GVDDVFLLAH AFSETGQNKR IPFEDRTGEC LKRTGASVAL TSISNVTAFF MAALIPIPAL RAFSLQAAVV VVFNFAMVLL IFPAILSMDL YRREDRRLDI FCCFTSPCVS RVIQVEPQAY TDTHDNTRYS PPPPYSSHSF AHETQITMQS TVQLRTEYDP HTHVYYTTAE PRSEISVQPV TVTQDTLSCQ SPESTSSTRD LLSQFSDSSL HCLEPPCTKW TLSSFAEKHY APFLLKPKAK VVVIFLFLGL LGVSLYGTTR VRDGLDLTDI VPRETREYDF IAAQFKYFSF YNMYIVTQKA DYPNIQHLLY DLHRSFSNVK YVMLEENKQL PKMWLHYFRD WLQGLQDAFD SDWETGKIMP NNYKNGSDDG VLAYKLLVQT GSRDKPIDIS QLTKQRLVDA DGIINPSAFY IYLTAWVSND PVAYAASQAN IRPHRPEWVH DKADYMPETR LRIPAAEPIE YAQFPFYLNG LRDTSDFVEA IEKVRTICSN YTSLGLSSYP NGYPFLFWEQ YIGLRHWLLL FISVVLACTF LVCAVFLLNP WTAGIIVMVL ALMTVELFGM MGLIGIKLSA VPVVILIASV GIGVEFTVHV ALAFLTAIGD KNRRAVLALE HMFAPVLDGA VSTLLGVLML AGSEFDFIVR YFFAVLAILT ILGVLNGLVL LPVLLSFFGP YPEVSPANGL NRLPTPSPEP PPSVVRFAMP PGHTHSGSDS SDSEYSSQTT VSGLSEELRH YEAQQGAGGP AHQVIVEATE NPVFAHSTVV HPESRHHPPS NPRQQPHLDS GSLPPGRQGQ QPRRDPPREG LWPPPYRPRR DAFEISTEGH SGPSNRARWG PRGARSHNPR NPASTAMGSS VPGYCQPITT VTASASVTVA VHPPPVPGPG RNPRGGLCPG YPETDHGLFE DPHVPFHVRC ERRDSKVEVI ELQDVECEER PRGSSSN //